Drug or treatment

Mirikizumab clinical trials

• 11Clinical trials
• 29Countries

Newest trials

All recruiting trials (11)

• Breast milk mirikizumab levels in lactating people using mirikizumab for IBS/IBD

  This study tests how much mirikizumab passes into breast milk for people who are breastfeeding while on mirikizumab for an approved condition.

  Recruiting at 2 sites Phase 4 Eli Lilly and Company · Glenview, Illinois and 19 other locations · NCT07612267

• Flu? No—A combination of an FXR activator and mirikizumab for adults with Crohn's disease

  This study tests whether adding the FXR activator LY4395089 to mirikizumab is better than mirikizumab alone for adults with moderately to severely active Crohn's disease.

  Recruiting at 53 sites Phase 2 Eli Lilly and Company · Scottsdale, Arizona and 70 other locations · NCT07483099

• Mirikizumab single versus two under-the-skin injections in healthy adults

  This trial will test if a single injection of mirikizumab solution is as safe and well-tolerated as two subcutaneous injections in healthy adults.

  Recruiting at 5 sites Phase 1 Eli Lilly and Company · Daytona Beach, Florida and 4 other locations · NCT07446101

• Mirikizumab for Crohn's Disease: See if it helps heal the bowel walls

  This trial tests whether mirikizumab can help patients with Crohn's disease achieve transmural healing.

  Recruiting at 5 sites Phase 4 Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives · Brest and 7 other locations · NCT07292012

• Early mirikizumab versus azathioprine for newly diagnosed moderate-to-severe ulcerative colitis

  This trial will test whether starting mirikizumab right away instead of beginning with azathioprine helps people newly diagnosed with moderate-to-severe ulcerative colitis who did not respond well to mesalazine and steroids.

  Recruiting Phase 4 University Hospital Schleswig-Holstein · Kiel · NCT07235904

• LY4268989 (MORF-057) with mirikizumab for adults with moderate-to-severe ulcerative colitis

  We will test whether adding LY4268989 to mirikizumab helps adults with moderate-to-severe ulcerative colitis get better control than mirikizumab alone.

  Recruiting at 136 sites Phase 2 Eli Lilly and Company · Scottsdale, Arizona and 146 other locations · NCT07186101

• Mirikizumab in Crohn's-related strictures: open-label, single-arm study

  This study tests whether mirikizumab can help adults with inflammatory strictures from Crohn's disease across several centers in Canada, the UK, and the US.

  Recruiting at 5 sites Phase 4 Alimentiv Inc. · Miami, Florida and 7 other locations · NCT06997965

• Mirikizumab with or without tirzepatide for adults with moderately to severely active Crohn's disease who are overweight or have obesity

  This trial tests whether adding tirzepatide to mirikizumab helps adults with moderately to severely active Crohn's disease who are overweight or have obesity.

  Recruiting at 174 sites Phase 3 Eli Lilly and Company · Dothan, Alabama and 182 other locations · NCT06937099

• Mirikizumab given at the same time as tirzepatide for adults with moderate-to-severe ulcerative colitis who are overweight or have obesity

  This will test whether giving mirikizumab together with tirzepatide helps adults with moderate-to-severe ulcerative colitis who are overweight or obese reduce UC symptoms and lose at least 10% of their body weight.

  Recruiting at 179 sites Phase 3 Eli Lilly and Company · Dothan, Alabama and 185 other locations · NCT06937086

• Evaluating Mirikizumab for Children with Crohn's Disease

  This study is testing a new medication called mirikizumab to see if it helps children with Crohn's disease feel better and manage their symptoms.

  Recruiting at 71 sites Phase 3 Eli Lilly and Company · Los Angeles, California and 80 other locations · NCT05509777

• Evaluating Mirikizumab for Children with Ulcerative Colitis or Crohn's Disease

  This study is testing if a medication called mirikizumab can help children with ulcerative colitis or Crohn's disease feel better over a long period of time.

  Recruiting at 39 sites Phase 3 Eli Lilly and Company · San Francisco, California and 68 other locations · NCT04844606

Quick answers

How many clinical trials of Mirikizumab are recruiting right now?

11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 29 countries. The most sites are in United States (9 trials), Canada (8 trials), Italy (7 trials), Poland (7 trials), Germany (7 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 4, Phase 4: 4, Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →